Ozaki Y, Tsurutani J, Mukohara T, Iwasa T, et al. Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B). Eur J Cancer 2022;171:193-202.
PMID: 35728379